Stay updated on BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial
Sign up to get notified when there's something new on the BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial page.

Latest updates to the BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial page
- Check7 days agoChange DetectedNo substantive content changes detected between the old and new page versions; the study details and related information appear unchanged.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. No user-facing changes to the trial record were detected.SummaryDifference0.1%

- Check36 days agoChange DetectedFooter revision indicator updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision updated to v3.4.2 and the older government funding status notice (v3.4.1) was removed. These are administrative page updates that do not alter study content or user actions.SummaryDifference0.5%

- Check71 days agoChange DetectedA site-wide notice about government funding and NIH operations was added (with a link to opm.gov). The page revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check78 days agoChange DetectedAdded a glossary toggle and updated the footer metadata to show Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, while removing the older variants Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

Stay in the know with updates to BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 1323495 Dose Tolerance & Inflammation Biomarkers Clinical Trial page.